Analyst Coverage
| Firm | Analyst |
|---|---|
|
Baird
|
Brian Skorney
|
|
Bank of America Securities
|
Geoff Meacham
|
|
Barclays
|
Gena Wang
|
|
BMO
|
Evan Seigerman
|
|
Canaccord Genuity
|
Whitney Ijem
|
|
Cantor Fitzgerald
|
Olivia Brayer
|
|
Cowen & Co.
|
Phil Nadeau, Ph.D.
|
|
Evercore ISI
|
Liisa Bayko
|
|
Goldman Sachs
|
Salveen Richter
|
|
Guggenheim Securities
|
Debjit Chattopadhyay
|
|
HC Wainwright
|
Andrew Fein
|
|
Jefferies
|
Michael Yee
|
|
J.P. Morgan
|
Jessica Fye
|
|
Maxim Group
|
Naz Rahman
|
|
Morgan Stanley
|
Matthew Harrison
|
|
Needham & Company
|
Joseph Stringer
|
|
Oppenheimer
|
Hartaj Singh
|
|
Piper Sandler
|
Do Kim
|
|
Raymond James
|
Danielle Brill
|
|
RBC
|
Brian Abrahams, M.D.
|
|
Stifel
|
Paul Matteis
|
|
SVB Securities
|
David Risinger
|
|
Truist Securities
|
Robyn Karnauskas
|
|
UBS Securities
|
Colin Bristow, M.D.
|
|
Wells Fargo
|
Mohit Bansal
|
Vertex Pharmaceuticals is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Vertex Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Vertex Pharmaceuticals or its management. Vertex Pharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.